We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
UnitedHealth Group (UNH) Stock Slides as Market Rises: Facts to Know Before You Trade
Read MoreHide Full Article
UnitedHealth Group (UNH - Free Report) closed the most recent trading day at $300.58, moving -1.16% from the previous trading session. This change lagged the S&P 500's daily gain of 0.14%. Meanwhile, the Dow gained 0.2%, and the Nasdaq, a tech-heavy index, added 0.27%.
Heading into today, shares of the largest U.S. health insurer had lost 3.01% over the past month, lagging the Medical sector's loss of 1.34% and the S&P 500's gain of 3.97%.
The upcoming earnings release of UnitedHealth Group will be of great interest to investors. The company's earnings report is expected on July 29, 2025. The company is forecasted to report an EPS of $5.08, showcasing a 25.29% downward movement from the corresponding quarter of the prior year. Meanwhile, the latest consensus estimate predicts the revenue to be $111.86 billion, indicating a 13.16% increase compared to the same quarter of the previous year.
For the full year, the Zacks Consensus Estimates are projecting earnings of $21.85 per share and revenue of $449.46 billion, which would represent changes of -21.01% and +12.29%, respectively, from the prior year.
Additionally, investors should keep an eye on any recent revisions to analyst forecasts for UnitedHealth Group. These revisions help to show the ever-changing nature of near-term business trends. As a result, we can interpret positive estimate revisions as a good sign for the business outlook.
Our research shows that these estimate changes are directly correlated with near-term stock prices. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.
The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has witnessed a 2.08% decrease. UnitedHealth Group presently features a Zacks Rank of #5 (Strong Sell).
In the context of valuation, UnitedHealth Group is at present trading with a Forward P/E ratio of 13.92. This represents a premium compared to its industry average Forward P/E of 12.94.
Meanwhile, UNH's PEG ratio is currently 1.46. The PEG ratio is akin to the commonly utilized P/E ratio, but this measure also incorporates the company's anticipated earnings growth rate. The average PEG ratio for the Medical - HMOs industry stood at 0.89 at the close of the market yesterday.
The Medical - HMOs industry is part of the Medical sector. At present, this industry carries a Zacks Industry Rank of 215, placing it within the bottom 13% of over 250 industries.
The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Ensure to harness Zacks.com to stay updated with all these stock-shifting metrics, among others, in the next trading sessions.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
UnitedHealth Group (UNH) Stock Slides as Market Rises: Facts to Know Before You Trade
UnitedHealth Group (UNH - Free Report) closed the most recent trading day at $300.58, moving -1.16% from the previous trading session. This change lagged the S&P 500's daily gain of 0.14%. Meanwhile, the Dow gained 0.2%, and the Nasdaq, a tech-heavy index, added 0.27%.
Heading into today, shares of the largest U.S. health insurer had lost 3.01% over the past month, lagging the Medical sector's loss of 1.34% and the S&P 500's gain of 3.97%.
The upcoming earnings release of UnitedHealth Group will be of great interest to investors. The company's earnings report is expected on July 29, 2025. The company is forecasted to report an EPS of $5.08, showcasing a 25.29% downward movement from the corresponding quarter of the prior year. Meanwhile, the latest consensus estimate predicts the revenue to be $111.86 billion, indicating a 13.16% increase compared to the same quarter of the previous year.
For the full year, the Zacks Consensus Estimates are projecting earnings of $21.85 per share and revenue of $449.46 billion, which would represent changes of -21.01% and +12.29%, respectively, from the prior year.
Additionally, investors should keep an eye on any recent revisions to analyst forecasts for UnitedHealth Group. These revisions help to show the ever-changing nature of near-term business trends. As a result, we can interpret positive estimate revisions as a good sign for the business outlook.
Our research shows that these estimate changes are directly correlated with near-term stock prices. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.
The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has witnessed a 2.08% decrease. UnitedHealth Group presently features a Zacks Rank of #5 (Strong Sell).
In the context of valuation, UnitedHealth Group is at present trading with a Forward P/E ratio of 13.92. This represents a premium compared to its industry average Forward P/E of 12.94.
Meanwhile, UNH's PEG ratio is currently 1.46. The PEG ratio is akin to the commonly utilized P/E ratio, but this measure also incorporates the company's anticipated earnings growth rate. The average PEG ratio for the Medical - HMOs industry stood at 0.89 at the close of the market yesterday.
The Medical - HMOs industry is part of the Medical sector. At present, this industry carries a Zacks Industry Rank of 215, placing it within the bottom 13% of over 250 industries.
The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Ensure to harness Zacks.com to stay updated with all these stock-shifting metrics, among others, in the next trading sessions.